$971 Million is the total value of Iron Triangle Partners LP's 26 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 62.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EHC | Sell | ENCOMPASS HEALTH CORP | $43,978,000 | -30.7% | 563,607 | -27.3% | 4.53% | -43.9% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $39,715,000 | +4.8% | 65,000 | -7.1% | 4.09% | -15.1% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $38,889,000 | +4.7% | 900,000 | -1.1% | 4.01% | -15.1% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $34,599,000 | -41.6% | 215,144 | -41.9% | 3.56% | -52.7% |
| LUNG | Sell | PULMONX CORP | $24,266,000 | -11.6% | 550,000 | -8.3% | 2.50% | -28.3% |
| OHPAU | Sell | ORION ACQUISITION CORPunit 02/19/2026 | $9,980,000 | -9.2% | 1,006,085 | -8.5% | 1.03% | -26.4% |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -100,000 | -100.0% | -0.56% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -100,000 | -100.0% | -0.69% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -160,000 | -100.0% | -1.13% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -100,000 | -100.0% | -1.68% | – |
| NTRA | Exit | NATERA INC | $0 | – | -150,000 | -100.0% | -1.94% | – |
| IQV | Exit | IQVIA HLDGS INC | $0 | – | -100,000 | -100.0% | -2.46% | – |
| SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -725,000 | -100.0% | -4.08% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -330,000 | -100.0% | -4.66% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -170,000 | -100.0% | -5.51% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -160,000 | -100.0% | -7.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.